Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

Clinical Trial ID NCT02360956

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02360956

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2009 1.77
2 Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab 2012 1.06
3 Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil. Vasc Health Risk Manag 2009 0.89
4 Effects of the Angiotensin receptor blocker olmesartan on adipocyte hypertrophy and function in mice with metabolic disorders. Biomed Res Int 2014 0.79
5 Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial. Trials 2016 0.75
Next 100